Streetbeat News

Price Targets

MLTX

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a 'Buy' rating on MoonLake (NASDAQ:MLTX) and maintained a $75 price target.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 10:24 am

CRBU

HC Wainwright & Co. analyst Robert Burns maintains a 'Buy' rating on Caribou Biosciences (NASDAQ:CRBU) but lowers the price target from $25 to $23.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 10:23 am

AWI

UBS analyst John Lovallo maintains a 'Sell' rating on Armstrong World Indus (NYSE:AWI) and raises the price target from $69 to $75.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 26, 2023 | 10:22 am

ATLX

HC Wainwright & Co. analyst Heiko Ihle initiates coverage on Atlas Lithium (NASDAQ:ATLX) with a Buy rating and announces a price target of $56.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 10:21 am

WDC

UBS analyst Timothy Arcuri maintains a Neutral rating on Western Digital (NASDAQ:WDC) and raises the price target from $35 to $42.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 26, 2023 | 10:19 am

GOOGL

Needham analyst Laura Martin maintains a Buy rating on Alphabet (NASDAQ:GOOGL) and raises the price target from $115 to $140.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 10:19 am

PHM

UBS analyst John Lovallo maintains a Buy rating on PulteGroup (NYSE:PHM) and raises the price target from $81 to $105.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 26, 2023 | 10:18 am

BIIB

HC Wainwright & Co. analyst Andrew Fein has reiterated a 'Buy' rating on Biogen (NASDAQ:BIIB) and maintained a price target of $325.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 10:17 am

GE

Barclays analyst Julian Mitchell maintains an Overweight rating on General Electric (NYSE:GE) and raises the price target from $125 to $131.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 26, 2023 | 10:16 am

DHR

Barclays analyst Luke Sergott maintains an Overweight rating on Danaher (NYSE:DHR) and raises the price target from $260 to $290.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 26, 2023 | 10:15 am